78 related articles for article (PubMed ID: 27193730)
1. Simpler alternative to CARCINOscreen(®) based on quantitative PCR (qPCR).
Saito F; Matsumoto H; Akahori Y; Takeyoshi M
J Toxicol Sci; 2016; 41(3):383-90. PubMed ID: 27193730
[TBL] [Abstract][Full Text] [Related]
2. CARCINOscreen®: New short-term prediction method for hepatocarcinogenicity of chemicals based on hepatic transcript profiling in rats.
Matsumoto H; Saito F; Takeyoshi M
J Toxicol Sci; 2014; 39(5):725-34. PubMed ID: 25242402
[TBL] [Abstract][Full Text] [Related]
3. Applicability of a gene expression based prediction method to SD and Wistar rats: an example of CARCINOscreen®.
Matsumoto H; Saito F; Takeyoshi M
J Toxicol Sci; 2015 Dec; 40(6):805-7. PubMed ID: 26558461
[TBL] [Abstract][Full Text] [Related]
4. Alternative Carcinogenicity Screening Assay Using Colon Cancer Stem Cells: A Quantitative PCR (qPCR)-Based Prediction System for Colon Carcinogenesis.
Bak Y; Jang HJ; Shin JW; Kim SJ; Chun HW; Seo JH; No SH; Chae JI; Son DH; Lee SY; Hong J; Yoon DY
J Microbiol Biotechnol; 2018 Apr; 28(4):645-651. PubMed ID: 29539880
[TBL] [Abstract][Full Text] [Related]
5. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
6. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
Thomas RS; Pluta L; Yang L; Halsey TA
Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
[TBL] [Abstract][Full Text] [Related]
7. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.
Auerbach SS; Shah RR; Mav D; Smith CS; Walker NJ; Vallant MK; Boorman GA; Irwin RD
Toxicol Appl Pharmacol; 2010 Mar; 243(3):300-14. PubMed ID: 20004213
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days.
Yafune A; Taniai E; Morita R; Nakane F; Suzuki K; Mitsumori K; Shibutani M
Arch Toxicol; 2013 Jun; 87(6):1141-53. PubMed ID: 23411599
[TBL] [Abstract][Full Text] [Related]
9. Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.
Ozden S; Turgut Kara N; Sezerman OU; Durasi İM; Chen T; Demirel G; Alpertunga B; Chipman JK; Mally A
Toxicol Appl Pharmacol; 2015 Dec; 289(2):203-12. PubMed ID: 26431795
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
Aravalli RN; Talbot NC; Steer CJ
World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
[TBL] [Abstract][Full Text] [Related]
11. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
12. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
[TBL] [Abstract][Full Text] [Related]
13. Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells.
Tsujimura K; Asamoto M; Suzuki S; Hokaiwado N; Ogawa K; Shirai T
Cancer Sci; 2006 Oct; 97(10):1002-10. PubMed ID: 16918996
[TBL] [Abstract][Full Text] [Related]
14. An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data.
Yamada F; Sumida K; Saito K
J Appl Toxicol; 2016 Feb; 36(2):296-308. PubMed ID: 26198598
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
16. Inferring transcription factor activity from microarray data reveals novel targets for toxicological investigations.
Souza TM; van den Beucken T; Kleinjans JCS; Jennen DGJ
Toxicology; 2017 Aug; 389():101-107. PubMed ID: 28743512
[TBL] [Abstract][Full Text] [Related]
17. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
18. RNA-Seq provides new insights in the transcriptome responses induced by the carcinogen benzo[a]pyrene.
van Delft J; Gaj S; Lienhard M; Albrecht MW; Kirpiy A; Brauers K; Claessen S; Lizarraga D; Lehrach H; Herwig R; Kleinjans J
Toxicol Sci; 2012 Dec; 130(2):427-39. PubMed ID: 22889811
[TBL] [Abstract][Full Text] [Related]
19. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies.
Allen DG; Pearse G; Haseman JK; Maronpot RR
Toxicol Pathol; 2004; 32(4):393-401. PubMed ID: 15307212
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]